Loading...
The challenges faced in developing novel drug radiation combinations in non-small cell lung cancer.
Harrow, S Hanna, G McDonald, F Chalmers, A
Harrow, S
Hanna, G
McDonald, F
Chalmers, A
Citations
Altmetric:
Abstract
Lung cancer is the most common cancer diagnosed in the UK. Outcomes for patients with this disease remain poor and new strategies to treat this disease require investigation. One potential option is to combine novel agents with radiotherapy in clinical studies. Here we discuss some of the important issues to consider when combining novel agents with radiotherapy, together with potential solutions as discussed at a recent Clinical Translational Radiotherapy Group (CTRad) workshop.
Description
Date
2016-11
Publisher
Collections
Files
Loading...
From CORE (MUCC)
Adobe PDF, 728.8 KB
Keywords
Type
Article
Citation
The challenges faced in developing novel drug radiation combinations in non-small cell lung cancer. 2016, 28(11):720-725 Clin Oncol